Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Kaletra”

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00103012
What this trial is testing

Drug Interactions of Echinacea, Ginseng, and Ginkgo Biloba Taken With Lopinavir/Ritonavir in Healthy Volunteers

Who this might be right for
Healthy
National Institutes of Health Clinical Center (CC) 47
Post-approval studies (Phase 4)Study completedNCT01471821
What this trial is testing

Study to Evaluate the Activity and Tolerability of Lopinavir/Ritonavir and Lamivudine Bitherapy in HIV Patients With Viral Suppression

Who this might be right for
HIV Infection
Juan A. Arnaiz 250
Not applicableStudy completedNCT01076179
What this trial is testing

Kaletra in Combination With Antiretroviral Agents

Who this might be right for
Human Immunodeficiency Virus
AbbVie (prior sponsor, Abbott) 502
Large-scale testing (Phase 3)Study completedNCT02150993
What this trial is testing

First-Line Treatment for HIV-2

Who this might be right for
HIV-2 Infection
ANRS, Emerging Infectious Diseases 210
Early research (Phase 1)Study completedNCT04386876
What this trial is testing

Bioequivalence Study of Lopinavir/Ritonavir 200/50 mg Film Tablet (World Medicine Ilac, Turkey) Under Fasting Conditions

Who this might be right for
Bioequivalence
World Medicine ILAC SAN. ve TIC. A.S. 30
Testing effectiveness (Phase 2)Study completedNCT00116636
What this trial is testing

Study of the 48-Week Virologic and Immunologic Response to Lopinavir/Ritonavir (Kaletra) in HIV Positive Adult Patients

Who this might be right for
HIV Infections
Therapeutic Concepts 40
Post-approval studies (Phase 4)UnknownNCT04738045
What this trial is testing

Comparison of Remdesivir Versus Lopinavir/ Ritonavir and Remdesivir Combination in COVID-19 Patients

Who this might be right for
Covid19
Ahmed Essam 90
Testing effectiveness (Phase 2)Study completedNCT00621166
What this trial is testing

Pharmacokinetics of Generic Lopinavir/Ritonavir in Pregnant Women

Who this might be right for
HIV Infections
The HIV Netherlands Australia Thailand Research Collaboration 20
Early research (Phase 1)Study completedNCT00767117
What this trial is testing

TMC125-TiDP2-C197: A Phase I Trial to Investigate the Pharmacokinetic Interaction Between Lopinavir/Ritonavir and TMC125 Both at Steady-state in Healthy Volunteers.

Who this might be right for
HIV
Tibotec Pharmaceuticals, Ireland 16
Post-approval studies (Phase 4)Study completedNCT00564772
What this trial is testing

Raltegravir Kaletra Pharmacokinetics

Who this might be right for
Healthy
Allina Health System 15
Post-approval studies (Phase 4)Study completedNCT00234975
What this trial is testing

Safety of Lopinavir/Ritonavir (Kaletra) in HIV/HCV Co-infected Subjects vs Baseline Liver Biopsy Metavir Score

Who this might be right for
HIV Infection
AbbVie (prior sponsor, Abbott) 86
Large-scale testing (Phase 3)Study completedNCT01196195
What this trial is testing

KONCERT A Kaletra ONCE Daily Randomised Trial of the Pharmacokinetics, Safety and Efficacy of Twice-daily Versus Once-daily Lopinavir/Ritonavir Tablets Dosed by Weight as Part of Combination Antiretroviral Therapy in Human Immunodeficiency Virus-1 (HIV-1) Infected Children (PENTA 18)

Who this might be right for
Antiretroviral Therapy in HIV-1 Infected Children
PENTA Foundation 173
Not applicableStudy completedNCT05024006
What this trial is testing

Public Health Emergency: SOLIDARITY TRIAL Philippines

Who this might be right for
Covid19
University of the Philippines 1,314
Post-approval studies (Phase 4)Study completedNCT01234116
What this trial is testing

Post-Exposure Prophylaxis in Health Care Workers

Who this might be right for
Human Immunodeficiency Virus
Henry Ford Health System 16
Not applicableStudy completedNCT00474201
What this trial is testing

Drug Interaction Study of Lopinavir/Ritonavir and Gemfibrozil

Who this might be right for
Healthy Volunteers
National Institutes of Health Clinical Center (CC) 15
Post-approval studies (Phase 4)Study completedNCT02348177
What this trial is testing

Pharmacokinetics of Lopinavir/Ritonavir Superboosting in Infants and Young Children Co-infected With HIV and TB

Who this might be right for
Acquired Immunodeficiency SyndromeTuberculosis
Drugs for Neglected Diseases 96
Not applicableWithdrawnNCT01165645
What this trial is testing

Lopinavir and Ritonavir in Improving Immune Response to Vaccines in Patients With Complete Remission Following A Bone Marrow Transplant for Hodgkin Lymphoma

Who this might be right for
Hodgkin LymphomaStage I Adult Hodgkin LymphomaStage II Adult Hodgkin Lymphoma+2 more
Mayo Clinic
Testing effectiveness (Phase 2)Ended earlyNCT01601626
What this trial is testing

Rifampin-Based Tuberculosis Treatment Versus Rifabutin-Based Tuberculosis Treatment in Persons With HIV

Who this might be right for
HIV InfectionTuberculosis
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 71
Early research (Phase 1)Study completedNCT01227590
What this trial is testing

Pharmacokinetic Interactions Between an Herbal Medicine (African Potato) and Antiretroviral Agents (Lopinavir/Ritonavir)

Who this might be right for
Drug InteractionsHuman Immunodeficiency Virus
University of California, San Francisco 18
Early research (Phase 1)WithdrawnNCT01231451
What this trial is testing

Depot Contraception With and Without Lopinavir/Ritonavir

Who this might be right for
HIV Infection
St Stephens Aids Trust 10
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation